CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Universitätsklinikum des Saarlandes · Leipzig University · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
809
total citations
- FWCI
- 27.52
- Percentile
- 100%
- References
- 22
Citations per year
Authors
21Topics & keywords
Topics
Keywords
- Medicine
- Rituximab
- CHOP
- Diffuse large B-cell lymphoma
- Open label
- Internal medicine
- Oncology
- Lymphoma
UN Sustainable Development Goals
- Partnerships for the goals
No related works found for this paper.